Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving virus or bacteriophage
Patent
1994-05-09
1997-11-11
Mosher, Mary E.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving virus or bacteriophage
435975, 436518, 530324, 530403, C12Q 170, G01N 33543, C07K 14005, C07K 1700
Patent
active
056862393
ABSTRACT:
Peptide antigens are provided which are derived from the enterically transmitted non-A
on-B viral hepatitis agent, known as hepatitis E virus (HEV). The HEV derived peptides and in particular, SG3, are immunoreactive with sera from individuals infected with HEV. The antigens are useful as diagnostic reagents in diagnostic methods and kits for determining infection of an individual with HEV.
REFERENCES:
Bradley, D.W., et al., "Enterically transmitted non-A, non-B hepatitis: Serial passage of disease in cynomolgus macaques and tamarins and recovery of disease-associated 27-to 34-nm viruslike particles", Proc. Natl. Acad. Sci. USA 84(17):6277-81 (1987).
Dawson, G.J., et al., "Solid-phase enzyme-linked immunosorbent assay for hepatitis E virus IgG and IgM antibodies utilizing recombinant antigens and synthetic peptides" J. Virol. Methods 38(1):175-86 (1992).
Huang, C.-C., et al., "Molecular Cloning and Sequencing of the Mexico Isolate of Hepatitis E Virus (HEV)", Virology 191(2):550-8 (1992).
Kaur, M., et al., "Human linear B-cell epitopes encoded by the hepatitis E virus include determinants in the RNA-dependant RNA polymerase" Proc. Natl. Acad. Sci. USA 89 (May):3855-8 (1992).
Khudyakov, Y.E., et al., "Epitope Mapping in Proteins of Hepatitis E Virus", Virology 194(4):89-96 (1993).
Lok, A.S.F., et al., "Comparison of Reactivity to ORF 2 and ORF 3 HEV Antigens in IgG and IgM Anti-HEV Assasy", International Symposium on Viral Hepatitis and Liver Disease --Scientific Program and Abstract Volume, Abstract 694, p. 262.
Purdy, M.A., et al., "Expression of a hepatitis E virus (HEV)-trpE fusion protein containing epitopes recognized by antibodies in sera from human cases and experimentally infected primates", Archives of Virology 123(3-4):335-49 (1992).
Reyes, G.R., et al., "Isolation of a cDNA from the Virus Responsible for Enterically Transmitted Non-A, Non-B Hepatitis", Science 247(4948):1335-9 (1990).
Tam, A.W., et al., "Hepatitis E Virus (HEV): Molecular Cloning and Sequencing of the Full-Length Viral Genome" Virology 185(1):120-31 (1991).
Tsarev, A., et al., "ELISA for Antibody Hepatitis E Virus (HEV) Based on Complete Open-Reading Frame-2 Protein Expressed in Insect Cells: Identification of HEV Infection in Primates" J. Infect. Dis. 168(2):369-78 (1993).
Yarbough, P.O., et al., "Hepatitis E Virus: Identification of Type-Common Epitopes", J. Virol. 65(11):5790-7 (1991).
Reyes Gregory R.
Tam Albert W.
Yarbough Patrice O.
Brookes Allan A.
Dehlinger Peter J.
Genelabs Technologies, Inc.
Mosher Mary E.
Sholtz Charles K.
LandOfFree
Hepatitis E virus peptides and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hepatitis E virus peptides and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hepatitis E virus peptides and methods will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1227781